The prescription-only IB-Stim device is a small, battery-powered electrical nerve stimulator that is placed behind the ear and emits low-frequency electrical pulses to stimulate branches of cranial nerves, a technique believed to provide pain relief. The single-use device is worn for five days before being replaced, and can be used consistently for up to three weeks.
The FDA’s clearance came after a clinical study showed that adolescent IBS patients who used the device to treat their abdominal pain experienced significant decreases in their pain over the course of three weeks. IB-Stim can be used in tandem with a patient’s existing medication regimen for IBS-related chronic abdominal pain.
More articles about health IT:
Cleveland Clinic study finds electronic inhaler usage reduces COPD-related hospitalizations
Most health system CFOs lack agreeable cooperation with CIOs, survey finds
Google’s 5 latest health-related job openings
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
